Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma
Belal Abousaida(WinnMed), Sunil Krishnan(Smith Family), Christopher L. Hallemeier(Mayo Clinic in Arizona), Aroumougame Asaithamby(The University of Texas Southwestern Medical Center), Kabir Mody(Mayo Clinic in Florida), Bradford S. Hoppe(Jacksonville College), Jonathan B. Ashman(Mayo Clinic in Arizona), Beau Toskich(Jacksonville College), Jessica Kirwan(University of Florida), Danushka S. Seneviratne, Francis A. Cucinotta(University of Nevada, Las Vegas), Stephen Ko(Mayo Clinic in Florida)
Cited by 14
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445